Ladu Adama Isah, Jeffery Caroline, Farate Abubakar, Farouk Abubakar G, Abulfathi Fatima M, Adekile Adekunle, Bates Imelda
Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK.
Department of Haematology, Faculty of Basic Clinical Sciences, University of Maiduguri, Maiduguri, Nigeria.
Ultrasound. 2024 Nov;32(4):260-269. doi: 10.1177/1742271X241241778. Epub 2024 Apr 8.
Ultrasonography is an established and reliable method for assessing the spleen. Because of variation due to genetic and other environmental factors including malaria endemicity, interpretation of spleen sizes requires a knowledge of the normal reference range for a given population. This study aimed to identify spleen size reference ranges across age groups of healthy controls to serve as a baseline to assess changes in spleen size in patients with sickle cell disease.
Using a cross-sectional study design, spleen size was measured in healthy people of different age groups and steady-state sickle cell disease patients (children and adults) using abdominal ultrasonography. Using the age-group-specific reference values obtained from the controls, spleens were classified into small, normal size or enlarged among the sickle cell disease patients.
The study consisted of 109 (34.8%) healthy controls and 204 (65.2%) steady-state sickle cell disease patients. The spleen was visualised in all the controls ( = 109) and in 107 (52.4%) sickle cell disease patients. Using cut-off values for spleen length among the controls across age groups (< 5 years (5.0-7.0 cm); 5-9 years (5.5-8.5 cm); 10-14 years (6.0-11.0 cm) and ⩾ 15 years (7.0-12.5 cm)), spleen size was classified as small ( = 18/204; 8.87%), normal ( = 68/204; 33.3%) and enlarged ( = 21/204; 10.3%) among the sickle cell disease patients.
Model-based age-group reference ranges and percentile curves for splenic dimensions based on ultrasonography among normal controls in North-Eastern Nigeria were established and may be of value in assessing spleen sizes among sickle cell disease patients living in malaria-endemic regions of Africa.
超声检查是评估脾脏的一种既定且可靠的方法。由于遗传和其他环境因素(包括疟疾流行情况)存在差异,解读脾脏大小需要了解特定人群的正常参考范围。本研究旨在确定健康对照各年龄组的脾脏大小参考范围,作为评估镰状细胞病患者脾脏大小变化的基线。
采用横断面研究设计,通过腹部超声检查测量不同年龄组健康人群以及稳定期镰状细胞病患者(儿童和成人)的脾脏大小。利用从对照中获得的特定年龄组参考值,将镰状细胞病患者的脾脏分为小、正常大小或肿大。
该研究包括109名(34.8%)健康对照和204名(65.2%)稳定期镰状细胞病患者。所有对照(n = 109)和107名(52.4%)镰状细胞病患者均可观察到脾脏。利用各年龄组对照的脾脏长度临界值(<5岁(5.0 - 7.0厘米);5 - 9岁(5.5 - 8.5厘米);10 - 14岁(6.0 - 11.0厘米)和⩾15岁(7.0 - 12.5厘米)),镰状细胞病患者的脾脏大小分为小(n = 18/204;8.87%)、正常(n = 68/204;33.3%)和肿大(n = 21/204;10.3%)。
在尼日利亚东北部正常对照中,基于超声检查建立了基于模型的各年龄组脾脏尺寸参考范围和百分位数曲线,这对于评估生活在非洲疟疾流行地区的镰状细胞病患者的脾脏大小可能具有价值。